.png)

This is Spoke 3 of the Hub 9 series: How Real Estate Developers Structure a $100M Closed-End Fund for Institutional LPs.
When a developer-operator takes a $100M closed-end real estate fund to institutional LPs, the first thing sophisticated allocators do is read the governance section. Not the promote structure. Not the fee schedule. The governance section.
They are looking for one thing: whether the fund is actually governable if the relationship breaks down.
GP removal rights sit at the center of that question. Most first-time fund managers treat these provisions as edge-case legal boilerplate. Institutional LPs treat them as a baseline credibility test. If the rights are missing, watered down, or drafted with thresholds that make them impossible to use, the LP's diligence team flags it. The raise gets harder.
Key takeaways from this guide:
Institutional LPs do not evaluate governance rights one by one. They evaluate them as a system. If one protection is weak, they scrutinize the others harder.
The table below shows the six rights that form the standard baseline in most institutional real estate fund LPAs, and why LPs insist on each one.
A GP that accepts this framework and drafts it with reasonable operational carveouts reads as experienced. A GP that resists any one of these rights without a credible structural reason raises an immediate flag. As the ILPA Principles frame it, governance, alignment, and transparency are the three non-negotiable pillars of institutional fund partnership.
More than 90% of institutional fund LPAs include for-cause GP removal rights. No serious LP will close without them. The only real question is how the right is structured.
Market-standard cause events typically include:
The vote threshold for for-cause removal is usually lower than for no-fault removal. A simple majority or 66.7% in interest is common, compared to the 75% or higher threshold used for without-cause removal.
The real negotiation is not over whether for-cause removal exists. It is over three things: the list of triggering events, whether a cure period applies, and what evidentiary standard governs the determination.
LPs generally accept a cure period of 30 to 60 days for curable breaches. They do not accept cure rights for fraud or willful misconduct. Those are non-curable by nature.
The credibility mistake: Trying to narrow the bad-act list so aggressively that it excludes obvious misconduct, or requiring a final court judgment before any removal can take effect. Both moves signal that the GP is trying to neutralize the remedy rather than draft it fairly.
No-fault removal allows LPs to remove the GP without proving misconduct. It does not require a triggering event. It is a last-resort mechanism for loss of confidence, chronic underperformance, or a fundamental breakdown in the relationship.
According to Preqin, 51% of North American institutional fund LPAs include without-cause removal provisions. And 18% of funds exercised those provisions in 2025. That number is not small. It reflects a real market where LPs are willing to use this right when they have to.
The deterrent effect is the real point. A GP who knows that 75% of its LP base can remove it without litigation behaves differently in fee disputes, conflict disclosures, and bad-news conversations.
The 75% threshold is the ILPA anchor. It is high enough to prevent a minority of disgruntled LPs from disrupting a functioning fund, and low enough to be reachable if a genuine LP majority has lost confidence.
The credibility mistake: Pushing the threshold to 80% or above. In a typical diversified LP base where no single LP holds more than 10-15% of the fund, 80% requires near-unanimous agreement. Institutional LPs recognize this immediately. It reads as an attempt to make the right unusable rather than a legitimate negotiating position.
Key person provisions are not about what happens if the GP entity is removed. They are about what happens if the people who actually run the fund stop showing up.
According to Preqin, 85% of institutional fund LPAs include time-and-attention provisions, and 50% link GP removal rights directly to key person misconduct. For a first-time developer-operator fund, where the entire investment thesis is built on one or two named principals, this clause carries enormous weight.
What first-time GPs miss: LPs do not just want named individuals listed. They want clear time-and-attention thresholds, defined trigger mechanics, and a succession logic that does not leave the fund in limbo. A vague key person clause reads as an afterthought.
The LP Advisory Committee is where governance either works or does not. Most first-time GPs accept the concept of an LPAC without understanding the distinction that actually matters to institutional LPs: whether LPAC rights are binding approvals or advisory consultations.
A GP-drafted LPA describes the LPAC as a body the GP "consults" or "keeps informed." That means the GP can proceed regardless of what the LPAC says. LP-favorable language requires LPAC approval, which creates a genuine blocking right. Institutional LPs know the difference immediately.
The real issue: Removal rights without workable successor mechanics are commercially useless. An LP that votes to remove the GP still needs the fund's real estate assets managed. If the LPA does not answer what happens next, the right is hollow. Institutional LPs will not accept a hollow right, and they will not pretend they did not notice. Understanding how to structure a real estate capital stack that passes LP diligence is the broader context in which governance terms sit.
The economic consequences of GP removal are heavily negotiated. The market does not have a single standard, but the range is well understood. Institutional LPs draw a clear line between without-cause removal and removal for serious misconduct, and they expect the carry treatment to reflect that distinction.
Without-cause removal:
For-cause removal (bad acts):
During key person suspension:
The credibility mistake: Treating all removal scenarios the same, or drafting economics that preserve full GP fees and carry regardless of the nature of the removal. Institutional LPs read that as a refusal to accept accountability. It is one of the fastest ways to lose credibility in a governance markup.
Governance terms do not just protect LPs. They signal whether a GP understands what institutional capital actually requires. These five mistakes consistently surface in first-time and early-fund diligence.
5 governance mistakes that kill institutional credibility:
The underlying message institutional LPs take from these mistakes is not that the GP is tough. It is that the GP has not done this before. That is a hard impression to reverse in a $100M raise. Understanding what institutional LPs require in GP promote structure and governance together is what separates a fundable document from one that generates endless diligence questions.
Market-standard removal rights are not the enemy. Badly drafted or defensively negotiated terms are.
A workable governance package does three things at once: it gives LPs genuine, usable protections; it preserves the GP's operational flexibility through clear carveouts; and it signals that the GP has structured funds before or has advisors who have.
Before taking your LPA into serious LP conversations, verify:
If your fund documents cannot pass that five-point check, they will not pass institutional diligence either. Book an institutional readiness review with IRC Partners to pressure-test your governance terms, GP control provisions, and LP positioning before your first LP conversation.
The institutional market anchor is 75 percent in interest, which is a threshold supported by global governance principles. While developers may attempt to push this to 80 percent or higher, institutional investors view anything above 75 percent as an attempt to make the right practically unreachable. This is especially true in a diversified fund where no single partner holds a dominant position.
For cause removal generally covers fraud, willful misconduct, gross negligence, material breach of the agreement, and entity level insolvency. While curable breaches may have a 30 to 60 day window for remediation, bad boy acts like fraud or willful misconduct are non-curable. These events typically trigger immediate removal rights without a cure period.
The standard window is 90 to 180 days. During this time, the investment period is suspended. The developer must propose a replacement for committee approval. If no suitable successor is found within this timeframe, investors usually vote to permanently terminate the investment period or liquidate the fund.
In most no fault cases, the developer retains their profit split on investments made prior to removal. However, they forfeit participation in all future investments. Clawback provisions remain in effect to ensure the developer does not walk away with overpaid distributions if the portfolio underperforms later in the fund life.
An advisory committee is a consultative body that the developer is not strictly required to follow. Conversely, a binding committee holds real approval rights over conflict of interest transactions and key person replacements. Institutional investors almost exclusively demand a binding committee to ensure genuine governance oversight and protection of capital.
Negotiation room for first time managers is narrow. While core items like committee oversight and for cause removal are non-negotiable, you can negotiate the specific mechanics. This includes the length of cure periods, specific successor approval timelines, and the economic haircut on management fees following a removal event.
Under institutional guidelines, management fees are typically suspended during a key person event. Some real estate funds negotiate a partial fee to cover the operational costs of finding a replacement, but an agreement that allows full fees to continue during a suspension is a major red flag for institutional investors.
Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call. IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.